The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab plus ipilimumab in advanced hepatocellular carcinoma with Child-Pugh B: A multicenter retrospective study.
 
Jung Sun Kim
No Relationships to Disclose
 
Youngun Kim
No Relationships to Disclose
 
Beodeul Kang
No Relationships to Disclose
 
Chansik An
No Relationships to Disclose
 
Ilhwan Kim
No Relationships to Disclose
 
Hyeyeong Kim
No Relationships to Disclose
 
Chan Kim
Honoraria - BMS; MSD; Ono Pharmaceutical; Roche
Consulting or Advisory Role - BMS; MSD; Oncocross; ONEGENE BIOTECHNOLOGY; Ono Pharmaceutical; Panolos Bioscience
Research Funding - Boryung; CHA vaccine institute; Dong-A ST; Oncocross; Roche (Inst); Samyang; Virocure
 
Hong Jae Chon
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; BMS; Eisai; MSD Oncology; Ono Pharmaceutical; Roche; Sanofi; SERVIER
Speakers' Bureau - AstraZeneca; Bayer; BMS; Dong-A ST; Eisai; Roche; Sanofi; SERVIER
Research Funding - BeiGene; Boryung (Inst); Dong-A ST (Inst); Hanmi; inno-n; Roche (Inst)
Travel, Accommodations, Expenses - Medivir (Inst)